PCN104 Cost Minimization Analysis (CMA) of Capecitabine/Cisplatin (XP) vs. 5-Fu/Cisplatin (FP) Regimens in Advanced Gastric Cancer (AGC) Treatment in the Romanian Setting
Abstract
Authors
S. Curescu D.L. Stanculeanu A. Croitoru C.P. Radu